Kedrion Biopharma
Marianna Mitolo currently serves as Group Treasury Sr. Director at Kedrion Biopharma since May 2023. Prior to this role, Marianna held the position of Group Treasury Director at Comdata Group from December 2020 to May 2023 and spent 15 years at Luxottica in various treasury roles, including Group Treasury Director, Deputy Group Treasurer, and Treasury Manager, specializing in treasury management in Asia and China. Marianna began their career as a Treasury Analyst, focusing on cash management, FX risk management, loan management, and financial reporting for emerging market entities. Marianna holds a degree in Economics and Finance from Università Bocconi, which was completed in 2005.
This person is not in any teams
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.